European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 173-180 , May 2008

Barriers to obesity treatment

  • Marina Mauro

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, ON, Canada
    • ,
  • Valerie Taylor

      Affiliations

    • Department of Psychiatry & Behavioral Neurosciences, McMaster University, Hamilton, ON, Canada
    • ,
  • Sean Wharton

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, ON, Canada
    • ,
  • Arya M. Sharma

      Affiliations

    • Department of Medicine, McMaster University, Hamilton, ON, Canada
    • Corresponding Author InformationCorresponding author. Canada Research Chair for Cardiovascular Obesity Research & Management, Department of Medicine McMaster University Hamilton General Hospital 237 Barton Street East Hamilton, ON, Canada, L8L 2X2. Tel.: +1 905 527 4322x46806; fax: +1 905 525 2260.

Received 14 June 2007 ,Revised 30 August 2007 ,Accepted 26 September 2007.

References 

  1. World Health Organization . Obesity: preventing and managing the global epidemic (who technical report series no. 894). Geneva: World Health Organization; 2000;
  2. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–643
  3. Katzmarzyk PT, Janseen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol. 2004;29:90–115
  4. Visscher TL, Rissanen A, Seidell JC, Heliövaara M, Knekt P, Reunanen A, et al. Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med. 2004;164:1413–1420
  5. Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res. 2001;9:788–805
  6. Pi-Sunyer FX. A review of long term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther. 1996;18:1006–1035
  7. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. Jan 4 2005;142:56–66
  8. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005;82:222S–225S
  9. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E, et al. Canadian clinical practice guidelines on management and prevention of obesity in adults and children. CMAJ. 2006;176:S1–S13
  10. Foster GD, Sarwer DB, Wadden TA. Psychological effects of weight cycling in obese persons: a review and research agenda. Obes Res. 1997;5:474–488
  11. Forman-Hoffman V, Little A, Wahls T. Barriers to obesity management: a pilot study of primary care clinicians. BMC Fam Pract. Jun 6 2006;7:35
  12. Merchant A, Yusuf S, Sharma AM. A cardiologist's guide to waist management. Heart. 2006;92:865–866
  13. Bray GA, Ryan DH. Drug treatment of the overweight patient. Gastroenterology. 2007;132:2239–2252
  14. Padwal R, Kezouh A, Levine M, Etminan M. Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes (Lond). Apr 10 2007;[Electronic publication ahead of print]
  15. Kral JG, Naslund E. Surgical treatment of obesity. Nat Clin Pract Endocrinol Metab. 2007;3:574–583
  16. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737
  17. Gastrointestinal surgery for severe obesity. National institutes of health consensus development conference statement. March 1991. Am J Clin Nutr. 1992;55:615S–619S
  18. Sobal J, Stunkard AJ. Socioeconomic status and obesity: a review of the literature. Psychol Bull. 1989;105:260–275
  19. Block JP, Scribner RA, DeSalvo KB. Fast food, race/ethnicity, and income: a geographic analysis. Am J Prev Med. 2004;27:211–217
  20. Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr. 2004;79:6–16
  21. Miles R, Panton L. The influence of the perceived quality of community environments on low-income women's efforts to walk more. J Commun Health. 2006;31:379–392
  22. Ruelaz AR, Diefenbach P, Simon B, Lanto A, Arterburn D, Shekelle PG. Perceived barriers to weight management in primary care—perspectives of patients and providers. J Gen Intern Med. 2007;22:518–522
  23. Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M, Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord. 2003;27:537–549
  24. Huerta S, Li Z, Li HC, Hu MS, Yu CA, Heber D. Feasibility of a partial meal replacement plan for weight loss in low-income patients. Int J Obes Relat Metab Disord. 2004;28:1575–1579
  25. Rollnick S. Behavior change in practice: targeting individuals. Int J Obes Relat Metab Disord. 1996;20:S22–S26
  26. Verheijden MW, Bakx JC, van Weel C, Koelen MA, van Staveren WA . Role of social support in lifestyle-focused weight management interventions. Eur J Clin Nutr. 2005;59:S179–S186
  27. Andrews G. Intimate saboteurs. Obes Surg. 1997;7:445–448
  28. Mustajoki P. Psychosocial factors in obesity. Ann Clin Res. 1987;19:143–146
  29. van Hout G, van Oudheusden I, van Heck G. Psychological profile of the morbidly obese. Obes Surg. 2004;14:579–588
  30. Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, et al. Binge eating disorder: its further validation in a multisite study. Intl J of Eat Disord. 1993;13:137–153
  31. Wadden TA, Sarwer DB, Womble LG, Foster GD, McGuckin BG, Schimmel A. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am. 2001;81:1001–1024
  32. Grilo CM, White MA, Masheb RM, Rothschild BS, Burke-Martindale CH. Relation of childhood sexual abuse and other forms of maltreatment to 12-month postoperative outcomes in extremely obese gastric bypass surgery. Obes Surg. 2006;16:454–460
  33. Janssen I, Craig WM, Boyce WF, Pickett W. Associations between overweight and obesity with bullying behaviors in school-aged children. Pediatrics. 2004;113:1187–1194
  34. Dingemans AE, Bruna MJ, Furth EF. Binge eating disorder: a review. Int J Obes. 2002;26:299–307
  35. McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR. Topiramate Binge Eating Disorder Research Group. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry. 2007;61:1039–1048
  36. McElroy SL, Kotwal R, Guerdjikova AI, Welge JA, Nelson EB, Lake KA, et al. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry. 2006;67:1897–1906
  37. Bocchieri-Ricciardi LE, Chen EY, Munoz D, Fischer S, Dymek-Valentine M, Alverdy JC, et al. Pre-surgery binge eating status: effect on eating behavior and weight outcome after gastric bypass. Obes Surg. 2006;16:1198–1204
  38. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107
  39. Fava M. Weight gain and antidepressants. J Clin Psychiatry. 2000;61:37–41
  40. Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry. 2002;2:9–18
  41. Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med. 2005 Jan 10;165(1):25–30
  42. Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol. 2005;6(6):341–347
  43. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin N Am. 2003;32:869–894
  44. Resta O, Foschino-Barbaro MP, Legari G, Talamo S, Bonfitto P, Palumbo A, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord. 2001;25:669–675
  45. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–2041
  46. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation. 2003;108:9–12
  47. Larsson UE, Mattsson E. Perceived disability and observed functional limitations in obese women. Int J Obes Relat Metab Disord. 2001;25:1705–1712
  48. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med. 1988;109:18–24
  49. Flamme CH. Obesity and low back pain: biology, biomechanics and epidemiology. Orthopade. 2005;34:652–657
  50. Patucchi E, Fatati G, Puxeddu A, Coaccioli S. Prevalence of fibromyalgia in diabetes mellitus and obesity. Recenti Prog Med. 2003;94:163–165
  51. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med. 2003;115(S8):37S–41S
  52. Pischon T, Sharma AM. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev. 2001;2:275–280
  53. Scholze J, Grimm E, Herrmann D, Unger T, Kintscher U. Optimal treatment of obesity-related hypertension: the Hypertension–Obesity–Sibutramine (HOS) study. Circulation. 2007;115:1991–1998
  54. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Inter Med. 2002;162:1477–1481
  55. Poulain M, Doucet M, Major GC, Drapeau V, Sériès F, Boulet LP, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ. 2006;174:1297–1299
  56. Hedberg A, Rossner S. Body weight characteristics of subjects on asthma medication. Int J Obes Relat Metab Disord. 2000;24:1217–1225
  57. Forslund HB, Lindroos AK, Blomkvist K, Hakeberg M, Berggren U, Jontell M, et al. Number of teeth, body mass index, and dental anxiety in middle-aged Swedish women. Acta Odontol Scand. 2002;60:346–352
  58. Hampel H. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199–211
  59. Nishizawa T, Suzuki H, Nomoto Y, Masaoka T, Hosoda H, Mori M, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther. 2006;24(Suppl 4):104–110
  60. Stoa-Birketvedt G, Paus PN, Ganss R, Ingebretsen OC, Florholmen J. Cimetidine reduces weight and improves metabolic control in overweight patients with type 2 diabetes. Int J Obes Relat Metab Disord. 1998;22:1041–1045
  61. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;1:CD004096
  62. Thamer C, Machann J, Stefan N, Haap M, Schafer S, Brenner S, et al. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity. 2007;15:531–538
  63. Pittas AG, Roberts SB. Dietary composition and weight loss: can we individualize dietary prescriptions according to insulin sensitivity or secretion status?. Nutr Rev. 2006;64:435–448
  64. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am. 2003;32:895–914
  65. Plotz CM, Knowlton AI, Ragan C. The natural history of Cushing syndrome. Am J Med. 1952;13:597–614
  66. Orth DN. Cushing syndrome. N Engl J Med. 1995;332:791–803
  67. Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, et al. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int J Obes Relat Metab Disord. 1995;19:614–624
  68. Ness-Abramof R, Apovian CM. Drug-induced weight gain. Drugs Today. 2005;41:547–555
  69. United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med. 1998;128:165–175
  70. Fonseca V. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med. 2003;115:42S–48S
  71. Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997;102:99–110
  72. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;2:CD003639
  73. Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298:194–206
  74. Gough SC. A review of human and analogue insulin trials. Diabetes Res Clin Pract. 2007;77:1–15
  75. Zimmermann U, Kraus T, Himmerich H, Schuld A, Pollmächer T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res. 2003;37:193–220
  76. Raeder MB, Bjelland I, Emil Vollset S, Steen VM. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry. 2006;67:1974–1982
  77. McElroy SL, Frye MA, Altshuler LL, Suppes T, Hellemann G, Black D, et al. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord. 2007;9:426–434
  78. Schwartz TL, Nihalani N, Virk S, Jindal S, Chilton M. Psychiatric medication-induced obesity: a review. Obes Rev. 2004;5:115–121
  79. Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am. 2005;34:371–384
  80. Hirsch MS, Klibanski A. What price progress? Pseudo-Cushing's syndrome associated with antiretroviral therapy in patients with human immunodeficiency virus infection. Clin Infect Dis. 1998;27:73–75
  81. Pischon T, Sharma AM. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev. 2001;2:275–280
  82. Prentice AM. Alcohol and obesity. Int J Obes. 1995;19(S5):S44–S50
  83. Yeomans MR. Effects of alcohol on food and energy intake in human subjects: evidence for passive and active over-consumption of energy. Br J Nutr. 2004;92:S31–S34
  84. Suter PM. Alcohol, lipid metabolism and body weight. Ther Umsch. 2000;57:205–211
  85. Risser JA, Vash PD, Nieto L. Does prior authorization of sibutramine improve medication compliance or weight loss?. Obes Res. 2005;13:86–92
  86. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–761
  87. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–752
  88. Avidor Y, Still CD, Brunner M, Buchwald JN, Buchwald H. Primary care and subspecialty management of morbid obesity: referral patterns for bariatric surgery. Surg Obes Relat Dis. 2007;3:392–407

PII: S0953-6205(07)00270-1

doi: 10.1016/j.ejim.2007.09.011

European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 173-180 , May 2008

Article Tools